ResearcherUniversity of UtahNo recent work listed

Natalya Y Rapoport

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5030608881. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper

Papers 2

Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. Co-author DOI 10.1186/2050-5736-1-11 ↗
Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/j.1477-2574.2010.00249.x ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jill Shea · 2 shared papers, 2011–2013 · strength 0.08
- Paper Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. DOI 10.1186/2050-5736-1-11 ↗
- Paper Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. DOI 10.1111/j.1477-2574.2010.00249.x ↗
Courtney L. Scaife · 2 shared papers, 2011–2013 · strength 0.08
- Paper Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. DOI 10.1186/2050-5736-1-11 ↗
- Paper Genexol inhibits primary tumour growth and metastases in gemcitabine-resistant pancreatic ductal adenocarcinoma. DOI 10.1111/j.1477-2574.2010.00249.x ↗
Roohi Gupta · 1 shared paper, 2013 · strength 0.04
- Paper Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model. DOI 10.1186/2050-5736-1-11 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.